Literature DB >> 2504601

Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents.

M Pfaller1, R Gordee, T Gerarden, M Yu, R Wenzel.   

Abstract

Cilofungin (LY121019) was shown to have potent fungicidal activity against clinical isolates of Candida albicans and Candida tropicalis but not Candida parapsilosis. Fungicidal activity was evident against both replicating and non-replicating Candida albicans and was progressive over the first 12 h of incubation. The combination of cilofungin (LY121019) with anticapsin but not with amphotericin B, ketoconazole or 5-fluorocytosine resulted in synergistic fungicidal activity. This compound warrants further investigation of its safety and efficacy in the treatment of Candida infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504601     DOI: 10.1007/bf01967483

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

1.  Antibiotic tetaine--a selective inhibitor of chitin and mannoprotein biosynthesis in Candida albicans.

Authors:  S Milewski; H Chmara; E Borowski
Journal:  Arch Microbiol       Date:  1986-08       Impact factor: 2.552

2.  Evaluation of in vitro antifungal activity of LY121019.

Authors:  M Hobbs; J Perfect; D Durack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

Review 3.  Strategies in the treatment of systemic fungal infections.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1980-01-17       Impact factor: 91.245

4.  Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy.

Authors:  R Horn; B Wong; T E Kiehn; D Armstrong
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

5.  In vitro and in vivo anti-Candida activity and toxicology of LY121019.

Authors:  R S Gordee; D J Zeckner; L F Ellis; A L Thakkar; L C Howard
Journal:  J Antibiot (Tokyo)       Date:  1984-09       Impact factor: 2.649

6.  Anticapsin: an active site directed inhibitor of glucosamine-6-phosphate synthetase from Candida albicans.

Authors:  S Milewski; H Chmara; E Borowski
Journal:  Drugs Exp Clin Res       Date:  1986

7.  Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species.

Authors:  E D Spitzer; S J Travis; G S Kobayashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

  7 in total
  7 in total

1.  W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase.

Authors:  J Tang; T R Parr
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 2.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.

Authors:  V N Tariq; E M Scott; N E McCain
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

4.  Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.

Authors:  N Khardori; H Nguyen; L C Stephens; L Kalvakuntla; B Rosenbaum; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.

Authors:  K R Smith; K M Lank; W E Dismukes; C G Cobbs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-07       Impact factor: 3.267

6.  Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans.

Authors:  E Abdelmegeed; Mona Ibrahim Shaaban
Journal:  J Microbiol       Date:  2013-09-14       Impact factor: 3.422

Review 7.  Antifungal Peptides as Therapeutic Agents.

Authors:  Miguel Fernández de Ullivarri; Sara Arbulu; Enriqueta Garcia-Gutierrez; Paul D Cotter
Journal:  Front Cell Infect Microbiol       Date:  2020-03-17       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.